Synovasure® Alpha Defensin Lateral Flow Test
When You Need to Know Now
Synovasure® Alpha Defensin Lateral Flow Test
When You Need to Know Now
The first of its kind, the Synovasure Alpha Defensin Lateral Flow Test is specifically designed as an aid for the diagnosis of periprosthetic joint infection (PJI). The test delivers same day results with speed and accuracy.1
- Infection Management
Periprosthetic Joint Infection (PJI) is one of the most common complications following total joint arthroplasty.2 The Synovasure Alpha Defensin Lateral Flow Test offers a rapid and accurate positive/negative result (10 minutes) to aid in the diagnosis of PJI.
Sensitivity vs. standard of care criteria.1
Specificity vs. standard of care criteria.1
*Excluding samples with >20% blood
- Features
- Overview
The Synovasure Alpha Defensin Lateral Flow Test is a standalone, rapid device for detecting alpha defensin in synovial fluid. The test received FDA authorization in 2019 as a CLIA moderately complex test.
- Same-Day Results
Results in 10 minutes following performance of test.
- Performance Backed by Data
Demonstrates a high sensitivity (94.3%) and specificity (94.5%). In addition, results proven in clinical studies to be unaffected by:
- Minimal Fluid Requirement
Only needs 15 microliters of synovial fluid to perform test.
- Consistent Results
No statistically significant difference in performance of Synovasure Alpha Defensin Lateral Flow Test and Synovasure Alpha Defensin ELISA laboratory test.1
- Specifications
- Procedures
Infection Diagnostics
- Application
Revision Knee
Revision Hip
